ArticleThe Journal of biological chemistry2021
Correction: Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.
Kang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.